These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17455652)

  • 1. [Antivirals for herpesviruses and cytomegalovirus].
    Minematsu T
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():396-400. PubMed ID: 17455652
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential resistance to antiviral drugs in an immunocompromised patient with cytomegalovirus encephalitis.
    Wada T; Mase S; Shibata F; Shimizu M; Toma T; Yachie A
    J Clin Virol; 2010 Nov; 49(3):223-4. PubMed ID: 20801077
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of allitridin on acute and chronic mouse cytomegalovirus infection.
    Liu XL; Wang H; Li YN; Ge HX; Shu SN; Fang F
    Arch Virol; 2011 Oct; 156(10):1841-6. PubMed ID: 21604182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New inhibitors of human cytomegalovirus (HCMV) on the horizon.
    De Clercq E
    J Antimicrob Chemother; 2003 May; 51(5):1079-83. PubMed ID: 12697653
    [No Abstract]   [Full Text] [Related]  

  • 5. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus resistance testing: pitfalls and problems for the clinician.
    Drew WL
    Clin Infect Dis; 2010 Mar; 50(5):733-6. PubMed ID: 20100090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
    Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the susceptibility of human herpesviruses to antivirals.
    Agut H; Boutolleau D; Deback C; Bonnafous P; Gautheret-Dejean A
    Future Microbiol; 2009 Nov; 4(9):1111-23. PubMed ID: 19895215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in diagnosing herpesvirus infections.
    Morishima T
    Nagoya J Med Sci; 1999 Nov; 62(3-4):83-97. PubMed ID: 10689870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-herpetic chemotherapeutic drugs].
    Shiraki K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():792-7. PubMed ID: 12722318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral drugs.
    Balfour HH
    N Engl J Med; 1999 Apr; 340(16):1255-68. PubMed ID: 10210711
    [No Abstract]   [Full Text] [Related]  

  • 15. Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
    Nieman JA; Nair SK; Heasley SE; Schultz BL; Zerth HM; Nugent RA; Chen K; Stephanski KJ; Hopkins TA; Knechtel ML; Oien NL; Wieber JL; Wathen MW
    Bioorg Med Chem Lett; 2010 May; 20(10):3039-42. PubMed ID: 20403696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA encapsidation as a target for anti-herpesvirus drug therapy.
    Visalli RJ; van Zeijl M
    Antiviral Res; 2003 Jul; 59(2):73-87. PubMed ID: 12895691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections.
    Colgan R; Michocki R; Greisman L; Moore TA
    Am Fam Physician; 2003 Feb; 67(4):757-62, 675. PubMed ID: 12613729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahalogenated benzimidazole D-ribonucleosides are active against rat cytomegalovirus.
    Dittmer A; Woskobojnik I; Adfeldt R; Drach JC; Townsend LB; Voigt S; Bogner E
    Antiviral Res; 2017 Jan; 137():102-107. PubMed ID: 27871886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
    Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC
    Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient.
    Miller GG; Boivin G; Dummer JS; McConnell T; Becher MW; Kassim A; Tang YW
    Clin Infect Dis; 2006 Feb; 42(4):e26-9. PubMed ID: 16421783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.